【摘 要】
：
Pharmacological activities of some natural products diminish even disappear after purification.Here we explored the mechanisms underlying the decrease of acute oral toxicity of Coptidis Rhizoma extrac
【出 处】
：
2015第11届全国药物和化学异物代谢学术会议
论文部分内容阅读
Pharmacological activities of some natural products diminish even disappear after purification.Here we explored the mechanisms underlying the decrease of acute oral toxicity of Coptidis Rhizoma extract after purification.
其他文献
The liposoluble drug roxithromycin owing to its high log P value was chosen to research whether the placenta barrier has protective effect on fetuses in late pregnancy.
溃疡性结肠炎(UC)状态下体内一些代谢酶的功能与表达会发生改变,且近期有报道使用质子泵抑制剂奥美拉唑(OME)治疗溃疡性结肠炎(UC),因此本研究考察OME在UC模型大鼠不同病期肝、肾、肠微粒体中奥美拉唑代谢酶活性的变化.给予大鼠自由饮用5％葡聚糖硫酸钠(DSS)7天诱导急性期UC(UCA)大鼠模型,7天DSS后改正常饮水7天诱导恢复期UC(UCR)大鼠模型.同时制备UCA、UCR以及正常对照(N
天然黄酮黄芩素，具有良好的药理活性，但是溶解度低，在体内广泛的被UGT酶快速代谢严重的影响了它在人体的药效发挥。我们以前曾报道过两个8-位含氮的黄芩素衍生物(BA-a和BA-j)具有比黄芩素更好的溶解度和抗CDK1活性。但是这两个化合物的UGT代谢稳定性还没有被系统的评估。
Object: The wide application of herbal medicines containing steroids and their saponins has resulted in the high risk of herb-drug interactions (HDIs).
Bu-Zhong-Yi-Qi-Wan (BZYQW) is a prescription of traditional Oriental medicine native to China popularly and has been reported to have multiple biological activities, including immunomodulatory, anti-t
Colchicine (COL), an alkaloid existing in plants of Liliaceous colchicum, has been used in the treatment of gout and familial Mediterranean fever.
Furanoid 8-epidiosbulbin E acetate (EEA) is a major constituent of herbal medicine Dioscorea bulbifera L.(DB), a traditional Chinese medicine herb.
Background colquhounia root tablet, a typical traditional Chinese medicine is widely used in clinical practice for the treatedment of rheumatoid arthritis, systemic lupus erythematosus, and other conn
Objective Bufadienolides are a major class ofbioactive compounds derived from amphibian skin secretion.This work aim to characterize the sulfation of bufadienolides including conjugation position, the
目的 托卡朋和恩他卡朋是新型帕金森病治疗药物。本研究旨在探讨二者对UGTs活性抑制作用,预测UGT1A1抑制引发的潜在药物-药物相互作用(DDI)。方法 以混合人肝微粒体(HLM)及重组表达UGTs作为酶源,选用4-甲基伞形酮(4-MU)、三氟拉嗪(TFP)、N-3-羧丙基-4-羟基-1,8-萘酰亚胺(NCHN)分别为UGTs酶的广谱探针底物,UGT1A4和UGT1A1的特异性探针底物,评估托卡朋